Cardiovascular disease in kidney transplant recipients: The prognostic value of inflammatory cytokine genotypes

Transplantation

Volumn 89, Issue 8, 2010, Pages 1001-1008

  La Manna, Gaetano ^a   Cappuccilli, Maria L ^a,b   Cianciolo, Giuseppe ^a   Conte, Diletta ^a,b   Comai, Giorgia ^a   Carretta, Elisa ^a   Scolari, Maria P ^a   Stefoni, Sergio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cardiovascular disease; Cytokine polymorphisms; Inflammation; Kidney transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; EVEROLIMUS; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VALIDATION STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; ITALY; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77951288477     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ce243f     Document Type: Article

References (62)

1. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603.
2. Matas AJ, Gillingham KJ, HumarA, et al. 2202 kidney transplant recipients with 10 years of graft function: What happens next? Am J Transplant 2008; 8: 2410.
3. Aakhus S, Dahl K, Wideroe TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 1999; 14: 648.
4. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84: 995.
5. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154.
6. Vanrenterghem YF, Claes K, Montagnino G, et al. Risk factors for cardiovascular events after successful renal transplantation. Transplantation 2008; 85: 209.
7. Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients: A prospective study. Kidney Int 2004; 66: 441.
8. Kiberd B, Panek R. Cardiovascular outcomes in the outpatient kidney transplant clinic: The Framingham risk score revisited. Clin J Am Soc Nephrol 2008; 3: 822.
9. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999; 340: 115.
10. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868.
11. Stoll G, Bendszus M. Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 2006; 37: 1923.
12. Patel S, Celermajer DS, Bao S. Atherosclerosis-underlying inflammatory mechanisms and clinical implications.IntJBiochem Cell Biol2008; 40: 576.
13. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 812.
14. Hao S, Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 2009; 10: 281.
15. Thakkinstian A, Dmitrienko S, Gerbase-Delima M, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: A meta-analysis of individual patient data. Nephrol Dial Transplant 2008; 23: 3017.
16. Goldfarb-Rumyantzev AS, Naiman N. Genetic prediction of renal transplant outcome. Curr Opin Nephrol Hypertens 2008; 17: 573.
17. Altun B, Yilmaz R, Kahraman S, et al. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients. Transpl Int 2005; 18: 681.
18. Hoffmann SC, Stanley EM, Darrin Cox E, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes. Transplantation 2001; 72: 1444.
19. Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009; 20: 43.
20. Warlé MC, Farhan A, Metselaar HJ, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003 Feb; 9(2): 170-181
21. Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, et al. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis 2003; 14: 431.
22. Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis fac-tor-a and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149.
23. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195.
24. Oregon-Romero E, Vazquez-Del Mercado M, Ruiz-Quezada SL, et al. Tumor necrosis factor alpha-308 and-238 polymorphisms in rheumatoid arthritis. Association with messenger RNA expression and sTNF-alpha. JInvestigMed 2008; 56: 937.
25. Teuffel O, Ethier MC, Beyene J, et al. Association between tumor necrosis factor-alpha promoter\308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: A systematic review and metaanalysis. Crit Care Med 2010 Jan; 38(1): 276-282
26. Cipriano C, Caruso C, Lio D, et al. The\308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int J Immunogenet 2005; 32: 13.
27. Sbarsi I, Falcone C, Boiocchi C, et al. Inflammation and atherosclerosis: The role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol 2007; 20: 145.
28. Bernard V, Pillois X, Dubus I, et al. The\308 G/A tumor necrosis-a gene dimorphism: A risk factor for unstable angina. Clin Chem Lab Med 2003; 41: 511.
29. Keso T, Perola M, Laippala P, et al. Polymorphisms within the tumor necrosis factor locus and prevalance of coronary artery disease in middle-aged men. Atherosclerosis 2001; 154: 691.
30. Kubota T, McNamara DM, Wang JJ, et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 1998; 97: 2499.
31. Pinderski Oslund LJ, HedrickCC, OlveraT, et al. IL-10 blocks atherosclerotic events in vitro and in vivo. ArteriosclerThromb Vasc Biol 1999; 19: 2823.
32. Han X, Kitamoto S, Lian Q, et al. Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages. J Biol Chem 2009; 284: 32950.
33. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1.
34. Reuss E, Fimmers R, Kruger A, et al. Differential regulation of interleukin-10 production by genetic and environmental factors\A twin study. Genes Immun 2002; 3: 407.
35. Koch W, Kastrati A, Bottiger C, et al. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001; 159: 137.
36. Bis JC, Heckbert SR, Smith NL, et al. Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 2008; 198: 166.
37. Girndt M, Kaul H, Sester U, et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002; 62: 949.
38. Kahraman S, Yilmaz R, Arici M, et al. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 2006; 19: 50.
39. Babel N, Cherepnev G, Kowalenko A, et al. Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants. Kidney Int 2004; 66: 428.
40. Asderakis A, Sankaran D, Dyer P, et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: The cytokine effect on transplantation. Transplantation 2001; 71: 674.
41. Bathgate AJ, Pravica V, Perrey C, et al. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation 2000; 69: 1514.
42. Girnita DM, Brooks MM, Webber SA, et al. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: A multi-institutional study. Transplantation 2008; 85: 1632.
43. Plaza DM, Fernandez D. Cytokine gene polymorphisms in heart transplantation: Association of low IL-10 production genotype with Quilty effect. J Heart Lung Transplant 2003; 22: 851.
44. Duquesnoy RJ, Demetris AJ. Immunopathology of cardiac transplant rejection. Curr Opin Cardiol 1995; 10: 193.
45. Grainger DJ, Kemp PR, Metcalfe JC, et al. The serum concentration of active transforming growth factor is severely depressed in advanced atherosclerosis. NatMed 1995; 1: 74.
46. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor in human disease. N Engl J Med 2000; 342: 1350.
47. Rahimi RA, Leof EB. TGF-beta signaling: A tale of two responses. J Cell Biochem 2007; 102: 593.
48. Stefoni S, Cianciolo G, Donati G, et al. Low TGF-/31 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int 2002; 61: 324.
49. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881.
50. Rao M, Guo D, Jaber BL, et al. Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int 2004; 66: 419.
51. Georges JL, Loukaci V, Poirier O, et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: The ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med 2001; 79: 300.
52. Remuzzi G, Cravedi P, Perna A, et al. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006; 354: 343.
53. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291.
54. Forsythe JL. Graft function and other risk factors as predictors of cardiovascular disease outcome. Transplantation 2001; 72: S16.
55. Ponticelli C, Villa M, Cesana B, et al. Risk factors for late kidney allograft failure. Kidney Int 2002; 62: 1848.
56. Soveri I, Holdaas H, Jardine A, et al. Renal transplant dysfunction\Importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality. Nephrol Dial Transplant 2006; 21: 2282.
57. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
58. Massy ZA, Chadefaux-Vekemans B, Chevalier A, et al. Hyperhomocys- teinaemia: A significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994; 9: 1103.
59. Audard V, Matignon M, Dahan K, et al. Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview. Transpl Int 2008; 21: 11.
60. Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: Mechanisms and implications. Am J Nephrol 2006; 26: 232.
61. Lentine KL, Rocca-Rey LA, Bacchi G, et al. Obesity and cardiac risk after kidney transplantation: Experience at one center and comprehensive literature review. Transplantation 2008; 86: 303.
62. Chang SH, Coates PT, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007; 84: 981.